BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 20827201)

  • 1. Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls.
    Labirua A; Lundberg IE
    Curr Opin Rheumatol; 2010 Nov; 22(6):633-8. PubMed ID: 20827201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiendothelial cell antibodies in inflammatory myopathies: distribution among clinical and serologic groups and association with interstitial lung disease.
    D'Cruz D; Keser G; Khamashta MA; Direskeneli H; Targoff IN; Miller F; Hughes GR
    J Rheumatol; 2000 Jan; 27(1):161-4. PubMed ID: 10648033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.
    Yoshifuji H; Fujii T; Kobayashi S; Imura Y; Fujita Y; Kawabata D; Usui T; Tanaka M; Nagai S; Umehara H; Mimori T
    Autoimmunity; 2006 May; 39(3):233-41. PubMed ID: 16769657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myositis-specific autoantibodies].
    Fujimoto M
    Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
    Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 65-year-old Woman With Persistent Dyspnea, Arthritis, and Raynaud's Phenomenon.
    Chong WH; Saha BK; Beegle S
    Am J Med Sci; 2021 Apr; 361(4):526-533. PubMed ID: 33386120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Myositis-Associated Interstitial Lung Disease.
    Fujisawa T
    Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33916864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome: recent advances.
    Hallowell RW; Danoff SK
    Curr Opin Rheumatol; 2014 Nov; 26(6):684-9. PubMed ID: 25203119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type.
    Johnson C; Connors GR; Oaks J; Han S; Truong A; Richardson B; Lechtzin N; Mammen AL; Casciola-Rosen L; Christopher-Stine L; Danoff SK
    Respir Med; 2014 Oct; 108(10):1542-8. PubMed ID: 25269710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antisynthetase syndrome].
    Gran JT
    Tidsskr Nor Laegeforen; 2002 Sep; 122(23):2270-2. PubMed ID: 12448266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Idiopathic inflammatory myopathies from the viewpoint of rheumatologists].
    Gono T; Katsumata Y; Kawaguchi Y
    Brain Nerve; 2013 Nov; 65(11):1275-82. PubMed ID: 24200605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease.
    La Corte R; Lo Mo Naco A; Locaputo A; Dolzani F; Trotta F
    Autoimmunity; 2006 May; 39(3):249-53. PubMed ID: 16769659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
    Wilkes MR; Sereika SM; Fertig N; Lucas MR; Oddis CV
    Arthritis Rheum; 2005 Aug; 52(8):2439-46. PubMed ID: 16052580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies.
    Mielnik P; Wiesik-Szewczyk E; Olesinska M; Chwalinska-Sadowska H; Zabek J
    Autoimmunity; 2006 May; 39(3):243-7. PubMed ID: 16769658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial lung disease as first clinical manifestation within the antisynthetase syndrome--dermatomyositis.
    Trăilă D; Mlădinescu OF; Oancea C; Tudorache V
    Pneumologia; 2015; 64(2):37-40. PubMed ID: 26506673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myositis-associated interstitial lung disease.
    Vu TTT; Brown KK; Solomon JJ
    Curr Opin Pulm Med; 2023 Sep; 29(5):427-435. PubMed ID: 37435671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].
    Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111
    [No Abstract]   [Full Text] [Related]  

  • 18. A Review of Antisynthetase Syndrome-Associated Interstitial Lung Disease.
    Patel P; Marinock JM; Ajmeri A; Brent LH
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myositis Antibodies and Interstitial Lung Disease.
    Basuita M; Fidler LM
    J Appl Lab Med; 2022 Jan; 7(1):240-258. PubMed ID: 34996093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The anti-Jo-1 syndrome - a specific form of myositis with interstitial lung disease].
    Häussermann A; Gillissen A; Seidel W
    Pneumologie; 2010 Aug; 64(8):496-503. PubMed ID: 20387195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.